Applikon and Finesse Announce Solution for Migrating 1010/1030 Controllers onto DeltaV
April 16, 2007 – Finesse Solutions, LLC, Applikon Biotechnology B.V. and Applikon BiotechnologyInc, announced the launch of a solution for migrating 1010/1030 controllers onto the DeltaV enabledTruLogic™ Controller and TruBio™ OS software. This solution, known as TruConnect™, is designed toenable users of either the Applikon 1010 and/or 1030 controllers to take full advantage of the additionalfunctionality available when these units are placed on a DeltaV controller enabled by the TruBio™ OS.
The role of TruConnect™ is to act as a serial interface between the Applikon 1010/1030 controller andDeltaV. To accomplish this role TruConnect™ converts the ASCII command set of the Applikon controllerand maps it to the Modbus protocol used by the TruBio™ OS. The design of TruConnect™ allowsfor a single DeltaV enabled TruLogic™ Controller to manage up to eight (8) of the Applikon 1010/1030units at a competitive price.
Applikon’s President, John Chory, stated, “The collaboration with Finesse has enabled us to ensureour customers that their substantial investment in our control products over the years can be easilymigrated to an Applikon supported DeltaV solution whenever they require.
”We developed our TruConnect™ technology to assist industry leaders such as Applikon in realizinga new, fast, reliable and cost competitive way of interfacing their devices to DeltaV,” said Larry West,Executive V.P. Sales and Marketing at Finesse.
About Finesse California based Finesse is a global leader in process measurement and control technologies. Ourfamily of products – TruBio™, TruLogic™, TruViu™, TruCell™, TrupH™, and TruDO™, provide comprehensive solutions for measurement and control processes in the biotech and pharmaceutical industries.For more information, please visit us at www.finesse.com
About Applikon Biotechnology B.V.Applikon Biotechnology is a privately owned Dutch company that develops, manufactures and suppliesbioreactor systems for research and production. Founded in 1973, Applikon has grown into a globalenterprise capable of supplying a broad and diverse line of bioreactor systems and a leading supplierof bioreactor solutions for R&D, Pilot and cGMP. Applikon’s autoclavable bioreactor systems are the worldwide industry standard. Applikon controllers comply with the highest standards applied in thepharmaceutical industry for bio-processes under GMP conditions.Applikon is headquartered in Schiedam, the Netherlands, with major operations in Foster City (USA),Eckington (UK), and distributors in more than 16 countries. For more information, please visit us at www.applikon-bio.com.